Pinteon Therapeutics
Kaj Blennow, M.D., Ph.D., is professor and academic chair in neurochemistry at University of Gothenburg, Sweden, and head of the clinical neurochemistry lab at Sahlgrenska University Hospital in Gothenburg. He holds the Torsten Söderberg Professorship at the Royal Swedish Academy of Sciences and serves as president of the Society for CSF Analysis and Clinical Neurochemistry and head of the Alzheimer’s Association QC program for CSF biomarkers. He received his M.D. from Lund University, Sweden.
This person is not in the org chart
This person is not in any offices
Pinteon Therapeutics
1 followers
Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease.